# Safety and Efficacy of Intracoronary Adult Human Mesenchymal Stem Cells After Acute Myocardial Infarction

> **NCT01392105** · PHASE2,PHASE3 · COMPLETED · sponsor: **Yonsei University** · enrollment: 80 (actual)

## Conditions studied

- Acute Myocardial Infarction

## Interventions

- **DRUG:** Mesenchymal stem cell
- **DRUG:** Control group

## Key facts

- **NCT ID:** NCT01392105
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2011-07-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01392105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01392105, "Safety and Efficacy of Intracoronary Adult Human Mesenchymal Stem Cells After Acute Myocardial Infarction". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01392105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*